Overview: Oxidized LDL TestIntroduction: The Oxidized LDL Test measures oxidized low-density lipoprotein (LDL) to diagnose cardiovascular risk, causing chest pain or stroke. Aligned with 2023 AHA guidelines, it uses biochemical methods for high specificity, supporting cardiac screening. This test is critical for guiding risk assessment, treatment planning, and improving outcomes in biochemistry for patients with suspected cardiovascular disease.
Other Names: OxLDL Assay, Oxidized Cholesterol Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Oxidized LDL testing began in the 1990s with atherosclerosis research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures oxidized LDL to diagnose cardiovascular risk, guides treatment, and evaluates patients with chest pain or stroke risk.
Test Parameters: 1. Oxidized LDL Level
Pretest Condition: No fasting required. Collect serum or plasma. Report history of chest pain, hypertension, or cardiovascular symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document chest pain, hypertension, or family history of cardiovascular disease. Include current medications, especially statins.
Consent: Written consent required, detailing the tests purpose, cardiovascular risk implications, and risks of sample collection.
Procedural Considerations: Uses immunoassays to measure oxidized LDL levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for cardiovascular risk assessment.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Oxidative stress markers may vary with diet.
Clinical Significance: Elevated oxidized LDL confirms cardiovascular risk, guiding statin therapy or lifestyle changes. Normal results may require lipid panel testing.
Specialist Consultation: Consult a cardiologist for result interpretation and treatment planning.
Additional Supporting Tests: Lipid panel, hs-CRP, or coronary artery calcium scan to confirm cardiovascular risk.
Test Limitations: Non-specific for certain cardiovascular conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: AHA Cardiovascular Guidelines, 2023; Circulation, Tsimikas S, 2022.
